Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease

Neurobiology of Aging

Volumn 34, Issue 9, 2013, Pages 2231-2233

  Müller, Sarina K ^a   Bender, Andreas ^a,b   Laub, Christoph ^a   Högen, Tobias ^a   Schlaudraff, Falk ^c   Liss, Birgit ^c   Klopstock, Thomas ^a,d,e,f   Elstner, Matthias ^a,d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Therapiezentrum Burgau ^*  (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e German Network for Mitochondrial Disorders (MitoNET)   (Germany)

^f GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Aging; Alzheimer's disease; Laser capture microdissection; LMD; Mitochondrial DNA; Mitochondrial dysfunction; MtDNA deletions; Parkinson's disease

Indexed keywords

MITOCHONDRIAL DNA; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; BRAIN MITOCHONDRION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA DETERMINATION; GENE DELETION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; LEWY BODY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; RESPIRATORY CHAIN; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; DNA DAMAGE; DNA, MITOCHONDRIAL; FEMALE; HUMANS; LEWY BODIES; MALE; MESENCEPHALON; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; REACTIVE OXYGEN SPECIES;

EID: 84878920856     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.03.016     Document Type: Article

References (15)

1. Bender A., Krishnan K.J., Morris C.M., Taylor G.A., Reeve A.K., Perry R.H., Jaros E., Hersheson J.S., Betts J., Klopstock T., Taylor R.W., Turnbull D.M. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 2006, 38:515-517.
2. Bender A., Schwarzkopf R.M., McMillan A., Krishnan K.J., Rieder G., Neumann M., Elstner M., Turnbull D.M., Klopstock T. Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J.Neurol. 2008, 255:1231-1235.
3. Coskun P., Wyrembak J., Schriner S.E., Chen H.W., Marciniack C., LaFerla F., Wallace D.C. Amitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2012, 1820:553-564.
4. Cottrell D.A., Blakely E.L., Johnson M.A., Ince P.G., Turnbull D.M. Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 2001, 57:260-264.
5. Elstner M., Muller S.K., Leidolt L., Laub C., Krieg L., Schlaudraff F., Liss B., Morris C., Turnbull D.M., Masliah E., Prokisch H., Klopstock T., Bender A. Neuromelanin, neurotransmitter status and brainstem location determine the differential vulnerability of catecholaminergic neurons to mitochondrial DNA deletions. Mol. Brain 2011, 4:43.
6. Elstner M., Turnbull D.M. Transcriptome analysis in mitochondrial disorders. Brain Res. Bull. 2011, 88:285-293.
7. Itoh K., Weis S., Mehraein P., Müller-Höcker J. Defects of cytochrome c oxidase in the substantia nigra of Parkinson's disease: and immunohistochemical and morphometric study. Mov. Disord. 1997, 12:9-16.
8. Jellinger K.A. The role of α-synuclein in neurodegeneration - an update. Transl. Neurosci. 2012, 3:75-122.
9. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J.Neurochem. 1992, 59:776-779.
10. Krishnan K.J., Bender A., Taylor R.W., Turnbull D.M. Amultiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells. Anal. Biochem. 2007, 370:127-129.
11. Krishnan K.J., Ratnaike T.E., De Gruyter H.L., Jaros E., Turnbull D.M. Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease. Neurobiol. Aging 2011, 33:2210-2214.
12. Krishnan K.J., Reeve A.K., Samuels D.C., Chinnery P.F., Blackwood J.K., Taylor R.W., Wanrooij S., Spelbrink J.N., Lightowlers R.N., Turnbull D.M. What causes mitochondrial DNA deletions in human cells?. Nat. Genet. 2008, 40:275-279.
13. Lin M.T., Cantuti-Castelvetri I., Zheng K., Jackson K.E., Tan Y.B., Arzberger T., Lees A.J., Betensky R.A., Beal M.F., Simon D.K. Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease. Ann. Neurol. 2012, 71:850-854.
14. Parker W.D., Parks J., Filley C.M., Kleinschmidt-DeMasters B.K. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994, 44:1090-1096.
15. Reeve A.K., Park T.K., Jaros E., Campbell G.R., Lax N.Z., Hepplewhite P.D., Krishnan K.J., Elson J.L., Morris C.M., McKeith I.G., Turnbull D.M. Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons. Arch. Neurol. 2012, 69:385-393.